These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22219230)

  • 61. [Usefulness of NT-ProBNP as a biomarker of clinical status in outpatients with chronic heart failure].
    Casado JM; Díaz A; Suárez C
    Rev Esp Cardiol; 2008 Feb; 61(2):206-10. PubMed ID: 18364191
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum biomarkers for heart failure.
    Jarolim P
    Cardiovasc Pathol; 2006; 15(3):144-9. PubMed ID: 16697927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NT-proBNP in heart failure: therapy decisions and monitoring.
    Richards M; Troughton RW
    Eur J Heart Fail; 2004 Mar; 6(3):351-4. PubMed ID: 14987587
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BNP-guided therapy for heart failure.
    Piña IL; O'Connor C
    JAMA; 2009 Jan; 301(4):432-4. PubMed ID: 19176447
    [No Abstract]   [Full Text] [Related]  

  • 67. [Prognostic markers in heart failure. Current status].
    Farráis Villalba M; Rodríguez Esteban M
    Med Clin (Barc); 2010 Mar; 134(7):310-1. PubMed ID: 20053411
    [No Abstract]   [Full Text] [Related]  

  • 68. [TOPCAT study. Heart failure: spironolactone disappoints in the "problem patient"].
    Overbeck P
    MMW Fortschr Med; 2013 Dec; 155(21-22):26. PubMed ID: 24724258
    [No Abstract]   [Full Text] [Related]  

  • 69. [Brain natriuretic peptide as marker and factor of prognosis in chronic heart failure].
    Bugrimova MA; Savina NM; Vanieva OS; Sidorenko BA
    Kardiologiia; 2006; 46(1):51-7. PubMed ID: 16474311
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of novel biomarkers in heart failure: how and why?
    Koza Y
    Int J Cardiol; 2014; 172(1):e194-5. PubMed ID: 24444487
    [No Abstract]   [Full Text] [Related]  

  • 71. Neprilysin in Heart Failure: From Oblivion to Center Stage.
    Bayés-Genís A
    JACC Heart Fail; 2015 Aug; 3(8):637-40. PubMed ID: 26251091
    [No Abstract]   [Full Text] [Related]  

  • 72. The VALIDD study.
    Oh J; Kang SM
    Lancet; 2007 Sep; 370(9591):931; author reply 931-2. PubMed ID: 17869625
    [No Abstract]   [Full Text] [Related]  

  • 73. Empowering physical examination: the "laying on" of ultrasound.
    Kimura BJ; Demaria AN
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):602-4. PubMed ID: 19356488
    [No Abstract]   [Full Text] [Related]  

  • 74. Can we prevent heart failure with exercise?
    O'Connor CM; Ahmad T
    J Am Coll Cardiol; 2012 Dec; 60(24):2548-9. PubMed ID: 23158537
    [No Abstract]   [Full Text] [Related]  

  • 75. Glycosylated natriuretic peptides: the cardiologist's new sweetheart?
    Røsjø H; Omland T
    Heart; 2012 Jan; 98(2):95-6. PubMed ID: 21917656
    [No Abstract]   [Full Text] [Related]  

  • 76. Biomarkers in acute heart failure: from risk markers to therapeutic targets.
    Kalogeropoulos AP; Georgiopoulou VV; Butler J
    Congest Heart Fail; 2013; 19(2):51-2. PubMed ID: 23279262
    [No Abstract]   [Full Text] [Related]  

  • 77. Prospective Validation of the Redin-SCORE to Predict the Risk of Rehospitalization for Heart Failure in a Contemporary Cohort of Outpatients.
    Ferrero-Gregori A; Álvarez-García J; Solé González E; Mirabet Pérez S; Cinca J; Roig E;
    Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1224-1225. PubMed ID: 27528051
    [No Abstract]   [Full Text] [Related]  

  • 78. Using Biomarkers to Guide Heart Failure Therapy.
    Jaffe AS; Januzzi JL
    Clin Chem; 2017 May; 63(5):954-957. PubMed ID: 28280051
    [No Abstract]   [Full Text] [Related]  

  • 79. [Urinary measurement of N-terminal B type natriuretic peptide in patients with cardiac failure - highway or byway?].
    Collinson PO
    Rev Esp Cardiol; 2011 May; 64(5):355-7. PubMed ID: 21477913
    [No Abstract]   [Full Text] [Related]  

  • 80. Understanding and making good use of changes in natriuretic peptide levels in chronic heart failure.
    Latini R; Masson S
    Eur J Heart Fail; 2015 Aug; 17(8):758-9. PubMed ID: 26179952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.